These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29355073)

  • 21. Mixture drug-count response model for the high-dimensional drug combinatory effect on myopathy.
    Wang X; Zhang P; Chiang CW; Wu H; Shen L; Ning X; Zeng D; Wang L; Quinney SK; Feng W; Li L
    Stat Med; 2018 Feb; 37(4):673-686. PubMed ID: 29171062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dimensional generalized propensity score with application to omics data.
    Gao Q; Zhang Y; Liang J; Sun H; Wang T
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34410351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Right Tool for the Job: Choosing Between Covariate-balancing and Generalized Boosted Model Propensity Scores.
    Setodji CM; McCaffrey DF; Burgette LF; Almirall D; Griffin BA
    Epidemiology; 2017 Nov; 28(6):802-811. PubMed ID: 28817469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accounting for uncertainty in confounder and effect modifier selection when estimating average causal effects in generalized linear models.
    Wang C; Dominici F; Parmigiani G; Zigler CM
    Biometrics; 2015 Sep; 71(3):654-65. PubMed ID: 25899155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Causal inference for observational longitudinal studies using deep survival models.
    Zhu J; Gallego B
    J Biomed Inform; 2022 Jul; 131():104119. PubMed ID: 35714819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Causal inference based on counterfactuals.
    Höfler M
    BMC Med Res Methodol; 2005 Sep; 5():28. PubMed ID: 16159397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Propensity Score-Based Estimators With Multiple Error-Prone Covariates.
    Hong H; Aaby DA; Siddique J; Stuart EA
    Am J Epidemiol; 2019 Jan; 188(1):222-230. PubMed ID: 30358801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A general, multivariate definition of causal effects in epidemiology.
    Flanders WD; Klein M
    Epidemiology; 2015 Jul; 26(4):481-9. PubMed ID: 25946227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Competing risks modeling of cumulative effects of time-varying drug exposures.
    Danieli C; Abrahamowicz M
    Stat Methods Med Res; 2019 Jan; 28(1):248-262. PubMed ID: 28882094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propensity score methods in real-world epidemiology: A practical guide for first-time users.
    Loke YK; Mattishent K
    Diabetes Obes Metab; 2020 Apr; 22 Suppl 3():13-20. PubMed ID: 32250525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interpreting epidemiological evidence: how meta-analysis and causal inference methods are related.
    Weed DL
    Int J Epidemiol; 2000 Jun; 29(3):387-90. PubMed ID: 10869307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlling for confounding via propensity score methods can result in biased estimation of the conditional AUC: A simulation study.
    Galadima HI; McClish DK
    Pharm Stat; 2019 Oct; 18(5):568-582. PubMed ID: 31111682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Supplementary data collection with case-cohort analysis to address potential confounding in a cohort study of thromboembolism in oral contraceptive initiators matched on claims-based propensity scores.
    Eng PM; Seeger JD; Loughlin J; Clifford CR; Mentor S; Walker AM
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):297-305. PubMed ID: 18215000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Desideratum for evidence based epidemiology.
    Overhage JM; Ryan PB; Schuemie MJ; Stang PE
    Drug Saf; 2013 Oct; 36 Suppl 1():S5-14. PubMed ID: 24166219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Narrative Review of Methods for Causal Inference and Associated Educational Resources.
    Landsittel D; Srivastava A; Kropf K
    Qual Manag Health Care; 2020; 29(4):260-269. PubMed ID: 32991545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dimensional propensity score algorithm in comparative effectiveness research with time-varying interventions.
    Neugebauer R; Schmittdiel JA; Zhu Z; Rassen JA; Seeger JD; Schneeweiss S
    Stat Med; 2015 Feb; 34(5):753-81. PubMed ID: 25488047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Causal analysis approaches in epidemiology].
    Dumas O; Siroux V; Le Moual N; Varraso R
    Rev Epidemiol Sante Publique; 2014 Feb; 62(1):53-63. PubMed ID: 24388738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the role of marginal confounder prevalence - implications for the high-dimensional propensity score algorithm.
    Schuster T; Pang M; Platt RW
    Pharmacoepidemiol Drug Saf; 2015 Sep; 24(9):1004-7. PubMed ID: 25866189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies with many covariates and few outcomes: selecting covariates and implementing propensity-score-based confounding adjustments.
    Patorno E; Glynn RJ; Hernández-Díaz S; Liu J; Schneeweiss S
    Epidemiology; 2014 Mar; 25(2):268-78. PubMed ID: 24487209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Causal analyses of existing databases: no power calculations required.
    Hernán MA
    J Clin Epidemiol; 2022 Apr; 144():203-205. PubMed ID: 34461211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.